Form 4 holding
ex CEO, Director, 10%+ Owner
Protagenic Therapeutics, Inc.\new
- Security class
- Common Stock
- Shares / value
- 16,233
- Estimated value
- $67,204
- Report date
- 15 May 2025
- Price
- $4.14
- Ownership
- These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.